Phase II multicenter study of adjuvant S-1 for colorectal liver metastasis: survival analysis of N-SOG 01 trial

[11] Kato T(2012)Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial Br J Cancer 106 1268-1273

[12] Shimizu Y(2014)S-1 as adjuvant chemotherapy for stage III colon cancer: A randomized phase III study (ACTS-CC trial) Ann Oncol 25 1743-1749

[13] André T(2013)Phase II trial of adjuvant chemotherapy with S-1 for colorectal liver metastasis Ann Surg Oncol 20 475-481

[14] Boni C(2008)Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 125-135

[15] Mounedji-Boudiaf L(1999)Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 309-318

[16] Kuebler JP(2000)Indicators for treatment strategies of colorectal liver metastases Ann Surg 231 59-66

[17] Wieand HS(2004)Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 644-657

[18] O’Connell MJ(2005)Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases Ann Surg 241 715-722

[19] Haller DG(2002)Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 35 759-766

[20] Tabernero J(2009)Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel Ann Oncol 20 985-992

[11] Kato T(2012)Safety of UFT/LV and S-1 as adjuvant therapy for stage III colon cancer in phase III trial: ACTS-CC trial Br J Cancer 106 1268-1273

[12] Shimizu Y(2014)S-1 as adjuvant chemotherapy for stage III colon cancer: A randomized phase III study (ACTS-CC trial) Ann Oncol 25 1743-1749

[13] André T(2013)Phase II trial of adjuvant chemotherapy with S-1 for colorectal liver metastasis Ann Surg Oncol 20 475-481

[14] Boni C(2008)Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients Ann Surg 247 125-135

[15] Mounedji-Boudiaf L(1999)Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases Ann Surg 230 309-318

[16] Kuebler JP(2000)Indicators for treatment strategies of colorectal liver metastases Ann Surg 231 59-66

[17] Wieand HS(2004)Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival Ann Surg 240 644-657

[18] O’Connell MJ(2005)Effect of surgical margin status on survival and site of recurrence after hepatic resection for colorectal metastases Ann Surg 241 715-722

[19] Haller DG(2002)Trends in long-term survival following liver resection for hepatic colorectal metastases Ann Surg 35 759-766

[20] Tabernero J(2009)Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel Ann Oncol 20 985-992